P33 | ARLOCABTAGENE AUTOLEUCEL, A GPRC5D-TARGETED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1 SAFETY AND EFFICACY RESULTS IN PATIENTS WITH 1–3 PRIOR REGIMENS
- DOI
- 10.3324/haematol.2026.s2.14112
- Published
- 2026-04-12
- Container
- Haematologica
- Publisher
- Ferrata Storti Foundation (Haematologica)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2026.s2.14112,
title = {P33 | ARLOCABTAGENE AUTOLEUCEL, A GPRC5D-TARGETED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1 SAFETY AND EFFICACY RESULTS IN PATIENTS WITH 1–3 PRIOR REGIMENS},
author = {S. Bal and M. Htut and J. Berdeja and L. Anderson and A. Rossi and T. Gregory and L. Costa and H. Hu and Z. Guo and J. Chen and K. Jordahl and N. Sarkis and S. Ziyad and W.M. Kao and A. Kaeding and M. Burgess and O. Nadeem},
year = {2026},
journal = {Haematologica},
doi = {10.3324/haematol.2026.s2.14112},
url = {https://doi.org/10.3324/haematol.2026.s2.14112}
}RIS
TY - JOUR TI - P33 | ARLOCABTAGENE AUTOLEUCEL, A GPRC5D-TARGETED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1 SAFETY AND EFFICACY RESULTS IN PATIENTS WITH 1–3 PRIOR REGIMENS AU - S. Bal AU - M. Htut AU - J. Berdeja AU - L. Anderson AU - A. Rossi AU - T. Gregory AU - L. Costa AU - H. Hu AU - Z. Guo AU - J. Chen AU - K. Jordahl AU - N. Sarkis AU - S. Ziyad AU - W.M. Kao AU - A. Kaeding AU - M. Burgess AU - O. Nadeem PY - 2026 JO - Haematologica DO - 10.3324/haematol.2026.s2.14112 UR - https://doi.org/10.3324/haematol.2026.s2.14112 ER -
APA
Bal, S., Htut, M., Berdeja, J., Anderson, L., Rossi, A., Gregory, T., Costa, L., Hu, H., Guo, Z., Chen, J., Jordahl, K., Sarkis, N., Ziyad, S., Kao, W., Kaeding, A., Burgess, M., & Nadeem, O. (2026). P33 | ARLOCABTAGENE AUTOLEUCEL, A GPRC5D-TARGETED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1 SAFETY AND EFFICACY RESULTS IN PATIENTS WITH 1–3 PRIOR REGIMENS. Haematologica. https://doi.org/10.3324/haematol.2026.s2.14112
Source records
- crossref · retrieved 2026-09-26T05:04:49.982Z